Xtl Biopharmaceuticals (XTLB) Current Assets (2009 - 2025)
Xtl Biopharmaceuticals (XTLB) posted quarterly Current Assets of $166000.0 for Q4 2025, down 87.61% year-on-year from $1.3 million in Q4 2024, and down 87.61% on a QoQ basis from $1.3 million in Q4 2024.
Xtl Biopharmaceuticals (XTLB) Current Assets (2009 - 2025) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Current Assets for 14 consecutive years, with $166000.0 the latest figure, recorded in Q4 2025.
- Quarterly Current Assets fell 87.61% year-over-year to $166000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $166000.0 (down 87.61% YoY) and the FY2025 annual result came in at $166000.0, down 87.61% from the prior year.
- Current Assets eased to $166000.0 in Q4 2025 per XTLB's latest filing, from $1.3 million in the prior quarter.
- Over the last five years, Current Assets for XTLB reached as high as $6.6 million in Q2 2021 and fell as low as $166000.0 in Q4 2025.
- A 5-year average of $3.6 million and a median of $3.8 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets increased 1.9% — and 2025, when it slumped 87.61%.
- Year by year, Current Assets stood at $6.2 million in 2021, then slumped by 38.98% to $3.8 million in 2022, then plunged by 46.24% to $2.0 million in 2023, then plunged by 34.51% to $1.3 million in 2024, then sank by 87.61% to $166000.0 in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $166000.0, $1.3 million, and $2.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | 166,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 3.81 Mn |
| Jun 30, 2022 | 5.38 Mn |
| Dec 31, 2021 | 6.24 Mn |
| Jun 30, 2021 | 6.57 Mn |
| Dec 31, 2020 | 6.12 Mn |
| Dec 31, 2019 | 6.83 Mn |
| Dec 31, 2018 | 8.20 Mn |
| Dec 31, 2017 | 6.21 Mn |
| Dec 31, 2016 | 2.75 Mn |
| Sep 30, 2012 | 5.66 Mn |
| Dec 31, 2011 | 1.58 Mn |
| Sep 30, 2011 | 1.86 Mn |
| Dec 31, 2010 | 1.22 Mn |
| Sep 30, 2010 | 1.40 Mn |
| Dec 31, 2009 | 557,000.00 |
| Sep 30, 2009 | 749,000.00 |